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To the Editor: Syphilis in pregnancy is a significant cause of 
perinatal mortality and morbidity in South Africa.1 Yet, despite 
universal screening for all antenatal women, it has been re-
ported to be endemic in KwaZulu-Natal. However, such reports 
are based mainly on figures from regional and tertiary hospitals 
and therefore may not be a true reflection of the prevalence of 
syphilis in the pregnant population. In a recent study per-
formed at King Edward VIII Hospital, Patel et al.2 reported a 
prevalence of 9%.2  Reports from sexually transmitted disease 
clinics quote figures of 21% among pregnant women.3 The latter 
figures are probably biased as they pertain to a specific group 
with symptoms and signs. The aim of our study was to estab-
lish the prevalence of syphilis at antenatal clinics, at different 
levels of health care in KwaZulu-Natal, in the hope that it may 
give a broader population-based perspective of the prevalence 
in the metropolitan area. 
Method
The following sites representing different levels of health care 
were chosen: KwaMashu Polyclinic (KMPC) (community 
clinic), Addington Hospital (district level), Mahatma Gandhi 
Hospital (MGH) (regional level), and King Edward VIII Hos-
pital (KEH) (tertiary level). A community clinic was defined as 
an institution at which antenatal care and delivery are provided 
by midwives for low-risk pregnant women.  A district hospital 
is usually staffed by midwives and medical officers. A regional 
hospital usually has specialist staff, while a tertiary hospital has 
subspecialist disciplines and attends to high-risk patients.
All patients were screened for syphilis using the rapid 
plasma reagent (RPR) test during the study period. In addition, 
HIV serology was performed following pre-test counselling. 
Post-test counselling was provided to all those who were HIV 
antibody-positive.
An RPR result of ≥ 1:8 titres was regarded as an index of 
recent infection. The TPHA (Treponema pallidum haemagglutina-
tion assay), a specific test for syphilis, was performed in cases 
where the result was ≤ 1:4 titres to exclude false-positives.
HIV testing was done using two separate rapid test bedside 
tests, viz. the Determine HIV 1/2 (Abbott Laboratories, Ill., USA) 
and SmartCheck (World Diagnostics, USA) kits. If both tests 
were positive, then the test was indicative of HIV; if there was 
a discrepancy between the tests, a confirmatory enzyme-linked 
immunosorbent assay (ELISA) was performed in the virology 
laboratory.
Results
The clinical details of 1 856 antenatal patients in the various 
clinics are shown in Table I.
The overall mean age was 26 years (range 14 - 44 years) and 
mean parity 1 (range 0 - 8). The overall prevalence of syphilis 
was 3.9%. The prevalence of syphilis was highest at MGH 
(6.5%) and lowest at KEH (2%). 
The overall incidence of HIV was 26% (N = 474) in the study. 
The mean age of the positive patients was 28 years (range 14 - 
43 years). 
Discussion 
The sites in our study were chosen to reflect both high-risk 
and low-risk pregnant populations and to estimate an overall 
prevalence rate for syphilis in an urban setting. This approach 
may be open to criticism as most stillbirths and perinatal losses 
(some of which could be due to syphilis) occur at tertiary levels 
of health care. Yet the prevalence rates of syphilis were similar 
at all levels of health care.
This study shows that the overall prevalence of syphilis 
was 3.9%. This figure is surprising because previous studies 
from Durban within the last 10 years showed a prevalence of 
9 - 15%.2,4 
The dramatic fall in the incidence of syphilis in a short 
period of time may reflect a positive outcome resulting from 
the promotion of universal testing at all levels of health care by 
the Department of Health. However, there is no reason to be 
complacent as a figure of 4% is still too high. Figures from afflu-
ent societies are now < 1% and the economic costs of universal 
screening are being debated in these countries. Our study did 
not follow up the obstetric or neonatal outcome and no contact 
tracing and treatment of the partner was done. From a public 
health point of view it is important to trace and treat all contacts 
to eradicate an endemic condition.
Low prevalence rates may lead to a change in the attitude 
of the health care profession regarding the seriousness of this 
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condition. There are anecdotal reports of patients not being 
screened in the antenatal period. In our study 9 patients at 
Addington Hospital, for example, had no RPR results. The 
promotion of universal screening must be maintained in South 
Africa.
The fall in the prevalence rate of syphilis may also be due to 
the population-based advertising campaign by the National 
Department of Health on the dangers of sexually transmitted 
infections and the promotion of safe sexual practices. 
The prevalence rates of syphilis in this study ranged from 
2% at KEH and 3% at Addington, to 5% and 6% at KMPC and 
MGH respectively. The latter two institutions are in the same 
area and the polyclinic refers patients to MGH. The higher fig-
ures at these institutions may be reflective of a more mobile and 
lower socio-economic population than the population attending 
Addington and KEH.
Our figures show a disparity between those who were 
HIV-positive and syphilis serology-positive. One would have 
expected a higher prevalence of HIV in those who were infected 
with syphilis. Reasons for this disparity are difficult to explain 
and there is a need for more in-depth research regarding the 
laboratory technique used to test for syphilis, as the immune-
suppressed state may have a ‘prozone effect’ on serology and 
result in false-positive tests.
In conclusion, it is good to note a decreasing trend in the 
prevalence of syphilis, but public health education in the field 
of sexually transmitted diseases must be maintained and im-
proved. 
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Table I. Clinical details
                    Addington             King Edward KwaMashu Mahatma        Overall figures
                  Hospital                 VIII Hospital Polyclinic  Gandhi Hospital  
Total recruited per site   (N)      500                         500  500  356        1 856       
    Mean age (yrs)                  26 (13 - 43)             26 (15 - 45) 25 (14 - 42) 26 (14 - 44)
Mean parity (N)                  1 (0 - 6)                   1 (0 - 10)  1 (0 - 6)  2 (0 - 7)
Mean gestation (wks)            22 (6 - 39)               24 (6 - 40)  24 (8 - 36)  25 (12 - 35)
HIV status (N (%))
Positive                  109 (21.8)                140 (28.0)  137 (27.4)    88 (24.7)        474 (25.5)
Negative                  203 (40.6)                205 (41.0)  186 (37.2)  116 (32.6)        710 (38.3)
Unknown                  188 (37.6)                155 (31.0)  177 (35.4)  152 (43.0)        672 (36.2)
RPR test results (N (%))
Reactive                  15 (3)                      10 (2)  26 (5.2)  23 (6.5)        74 (3.9)
Non-reactive                  476 (95.2)                476 (95.2)  473 (94.6)  323 (90.7)        1 748 (94.2)
Unknown                  9 (1.8)                     14 (2.8)  1 (0.2)  10 (2.8)        34 (1.8)
TPHA test results (N (%))
Reactive                  6 (1.2)                     2 (0.4)  5 (1)  13 (2.65)        26 (1.4)
Treatment
Before delivery                  4 (26.7%)                10 (100%)  21 (80.7%) 17 (74%)        52 (70.3%)
Three doses before                2  (13.3%)               10(100%)  20 (76.9%) 16 (69.6%)       48 (64.9%)
delivery
Reactive syphilis = RPR titres ≥ 1:8.
RPR = rapid plasma reagent test; TPHA = Treponema pallidum haemagglutination assay. 
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